Using RWE to Inform Clinical Development and Designing Trials Around the Right Patients, Endpoints & Assumptions

9:30 am - Thursday 11th February 2027

  • Leverage RWD earlier in clinical development to assess patient populations, inform inclusion and exclusion criteria, and ensure trial designs reflect real-world clinical practice
  • Use real-world insights to challenge critical trial assumptions, from patient representativeness and stratification factors to expected treatment effects and endpoint selection
  • Support evidence-based go/no-go decisions by identifying where RWD can strengthen Phase III planning